{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/polymyalgia-rheumatica/diagnosis/when-to-suspect/","result":{"pageContext":{"chapter":{"id":"18cd5747-18a3-56ba-bc8b-4426d03187a4","slug":"when-to-suspect","fullItemName":"When to suspect","depth":2,"htmlHeader":"<!-- begin field 2660b6ca-28ea-4bca-a76f-66f94c1f1620 --><h2>When should I suspect polymyalgia rheumatica?</h2><!-- end field 2660b6ca-28ea-4bca-a76f-66f94c1f1620 -->","summary":"","htmlStringContent":"<!-- begin item eb29a50b-4615-404d-89f4-2186ffd3508e --><!-- begin field e7cc5abc-58c7-4e8d-a0ca-361ef5541b3d --><ul><li><strong>Suspect polymyalgia rheumatica (PMR) in a person over 50 years of age presenting with at least 2 weeks of the core symptoms of:</strong><ul><li><strong>Bilateral shoulder and/or pelvic girdle pain. </strong>Initially this may be unilateral but quickly becomes bilateral, is worse with movement, and interferes with sleep.<ul><li>Shoulder pain may radiate to the elbows and is the presenting feature in 70–95% of people.</li><li>Hip and neck pain is the presenting feature in 50–70% of people. Hip pain may radiate to the knees.</li></ul></li><li><strong>Stiffness lasting for at least 45 minutes </strong>after waking or periods of rest that may cause the person to have difficulty turning over in bed, rising from a bed or a chair, or raising their arms above shoulder height.</li></ul></li><li><strong>Additional features that may accompany these core symptoms include:</strong><ul><li>Low-grade fever, fatigue, anorexia, weight loss, and depression — systemic symptoms occur in 40–50% of people with PMR.</li><li>Bilateral upper arm tenderness — sometimes present.</li><li>Peripheral musculoskeletal signs — seen in approximately 50% of people and include:<ul><li>Carpal tunnel syndrome.</li><li>Peripheral arthritis (predominantly affecting the knees and wrists), which is asymmetric and self-limiting.</li><li>Swelling with pitting oedema of hands, wrists, feet, and ankles.</li></ul></li></ul></li><li><strong>Muscle strength is not usually impaired</strong>, but muscle pain may make testing difficult. If symptoms are protracted, disuse atrophy of muscle can occur, leading to muscle weakness.</li></ul><!-- end field e7cc5abc-58c7-4e8d-a0ca-361ef5541b3d --><!-- end item eb29a50b-4615-404d-89f4-2186ffd3508e -->","topic":{"id":"ce8b01ca-f53a-55a3-8d34-3f1c4627fe6a","topicId":"ad21d80a-1ea5-4ead-b50d-c84a90f81dfd","topicName":"Polymyalgia rheumatica","slug":"polymyalgia-rheumatica","lastRevised":"Last revised in January 2019","chapters":[{"id":"1422f739-c18d-5e1e-a304-97c38c53326d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"16d2834f-dff7-5cdb-a7f4-58e78255d2d2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e0b8f18b-6f9c-5652-83d0-dafbd8f023f1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"45868673-afab-57d2-a5d7-8e82c7a6a1d6","slug":"changes","fullItemName":"Changes"},{"id":"5b1ee373-bd86-5e9d-812b-4832f6246571","slug":"update","fullItemName":"Update"}]},{"id":"27cf37e3-9a75-54bf-b40c-a9a5d3ab8774","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f98bc06e-32e0-5d1b-955b-704d835dadfc","slug":"goals","fullItemName":"Goals"},{"id":"de16a1ee-5b79-561d-aa33-007310d41806","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"27fd23e5-8ea0-5fc4-a238-92290ecf2d96","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"07ae7b26-b61c-5b1d-a11a-2e2f8831b2b4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"40fc7a60-984c-568d-bca4-9c74b0dd12ad","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"51474ce0-d36a-55b4-be78-dce9cacb0267","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"05f711b1-05e6-5832-a014-0d48622761aa","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2ff5c538-1fb7-5d1b-bd20-0b559053d445","slug":"definition","fullItemName":"Definition"},{"id":"222a21f0-7691-5217-92ac-d0b454809378","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"40912c6f-7953-5028-8087-bfe412fe8144","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0c6caaf8-c9e3-5154-ad85-0639ce885933","slug":"complications","fullItemName":"Complications"},{"id":"7dad7582-0879-5b1d-a434-a7385c6bf62a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f0e2a168-bba6-5e5e-9290-792a786adf37","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"18cd5747-18a3-56ba-bc8b-4426d03187a4","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"d17676a0-b0c6-5edc-8a36-71ff56514267","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"5928ae5b-d1b2-5880-b5d0-520d3eefbbb3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42122189-74ea-5630-87b7-23f6266addc0","fullItemName":"Management","slug":"management","subChapters":[{"id":"047c46a8-6c2e-538d-b303-898bc35b204c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ad839214-35b0-58d1-b8ec-1d66a6be3eb0","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fa86dcab-a820-5a5f-a76d-e237364c1e7b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"caac4d3d-be17-58bd-b762-bb897b659611","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7cfd6eb7-5b49-52a2-aa31-f8bf0144547c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e0cae2d-7716-577b-8a6f-249f600698b5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e8a07059-cd02-573a-819c-26383cacb522","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d99f4de4-aa27-5079-811c-923190c5046a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a29113d9-3ec2-598e-9d77-05509c1df517","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f0e2a168-bba6-5e5e-9290-792a786adf37","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"d1dfdf93-1ab7-5425-a2de-78bb503f57e6","slug":"basis-for-recommendation-5f1","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 2904c13f-8e59-4bcc-86b1-148f39b08b06 --><h3>Basis for recommendation</h3><!-- end field 2904c13f-8e59-4bcc-86b1-148f39b08b06 -->","summary":null,"htmlStringContent":"<!-- begin item 5f11585b-07c0-486e-aea4-8a93b19edb48 --><!-- begin field 2f69ab44-1e24-442e-bcc0-36f42aa14891 --><p>These recommendations are largely based on the <em>British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guidelines for the management of polymyalgia rheumatica </em>(PMR) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">Dasgupta et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">Dasgupta, 2010</a>] and are supported by expert opinion in review articles on PMR [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">Ameer, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">Weyand, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">Gonz&aacute;lez-Gay, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">Matteson, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polymyalgia-rheumatica/references/\">BMJ Best Practice, 2018</a>].</p><!-- end field 2f69ab44-1e24-442e-bcc0-36f42aa14891 --><!-- end item 5f11585b-07c0-486e-aea4-8a93b19edb48 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}